NFSG
VRCA icon

Newbridge Financial Services Group’s Verrica Pharmaceuticals VRCA Stock Holding History

Newbridge Financial Services Group’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-300
Closed -$17.3K – 1407
2023
Q2 		$17.3K Buy
+300
New +$18.2K 0.01% 735

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Newbridge Financial Services Group's VRCA Position: Q3 2023 in Review

Newbridge Financial Services Group sold out of Verrica Pharmaceuticals (VRCA) in Q3 2023, closing a stake of 300 shares — an estimated $17.3K sold.

Newbridge Financial Services Group first reported a position in VRCA in Q2 2023 and held it in 1 quarter. The position peaked at $17.3K in Q2 2023. 67 funds tracked by Wall St. Rank hold VRCA as of Q3 2023.

  • Newbridge Financial Services Group reported no remaining Verrica Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 300 Verrica Pharmaceuticals shares in Q3 2023, an estimated $17.3K.
  • Newbridge Financial Services Group first reported a position in Verrica Pharmaceuticals in Q2 2023 and held it in 1 quarter.
  • Newbridge Financial Services Group's Verrica Pharmaceuticals position peaked at $17.3K in Q2 2023.
  • 67 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2023.

Based on Newbridge Financial Services Group's 13F filing for Q3 2023, filed 17 Oct 2023.